Evidence map›Paper›PMID 37065319›Full record

ArticleCureus2023

A Disguising Fast-Growing Metachronous Melanoma and COVID-19.

Alina Avram, Lucian G Scurtu, Mariana Costache, Olga Simionescu

Abstract readCase Reports
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alina AvramDepartment of Dermatology I, Colentina Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, ROU.
Lucian G ScurtuDepartment of Dermatology I, Colentina Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, ROU.
Mariana CostacheDepartment of Pathology, Bucharest University Emergency Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, ROU.
Olga SimionescuDepartment of Dermatology I, Colentina Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, ROU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An unusual case of a 52-year-old female with two metachronous melanomas is presented. An atypical fast-growing nodular melanoma appeared 18 months after the complete excision of an in situ melanoma and one month afterward a SARS-CoV-2 infection. Intra-nodal melanocytic proliferations were identified during lymph node assessment, raising important diagnostic and prognostic concerns. No melanoma susceptibility genes were found. This case report raises the question about the COVID-19 immunosuppression effect on the tumor microenvironment and the oncogenic potential of SARS-CoV-2. It also highlights the importance of clinical follow-up in melanoma patients, which was significantly delayed during the COVID-19 pandemic.

Indexed as

covid-19malignant melanomamultiple melanomasnodular melanomasars-cov-2skin cancer

Identifiers

PMID37065319
PMCPMC10101186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.